IDH1 and cancer: On the other hand, mutations of the genes encoding the IDH1 enzyme have also been found in several cancers, mainly in about 80% of low-grade gliomas and secondary GBMs, about 40% of T cell lymphomas and in about of 10% of myeloid leukemias [13,14].